Press release
Genital Warts Clinical Trials Assessment 2025: PDMA, EMA, FDA Approvals, Medication, IND, NDA Approval, Therapies, Mechanism of Action, NICE Approvals, Route of Administration and Companies by DelveInsight
Genital Warts Clinical Trials
As per DelveInsight's assessment, globally, Genital Warts pipeline constitutes 30+ key companies continuously working towards developing 30+ Genital Warts treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Genital Warts Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Request for Sample Report here @ https://www.delveinsight.com/report-store/genital-warts-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some of the key takeaways from the Genital Warts Pipeline Report:
• Genital Warts Companies across the globe are diligently working toward developing novel Genital Warts treatment therapies with a considerable amount of success over the years.
• Genital Warts companies working in the treatment market are ViroXis Corporation, bioRASI, LLC, Verrica Pharmaceuticals Inc., Orgenesis, Heber Biotec, Cassiopea, Novan, Peritech Pharma, Novartis and others, are developing therapies for the Genital Warts treatment
• Emerging Genital Warts therapies such as VP-102, SB206, CB-06-02, and others are expected to have a significant impact on the Genital Warts market in the coming years.
• In February 2025, Merck Sharp & Dohme LLC announced results of a Randomized, Worldwide, Placebo-Controlled, Double-Blind Study to Investigate the Safety, Immunogenicity, and Efficacy on the Incidence of HPV 16/18-Related CIN 2/3 or Worse of the Quadrivalent HPV (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine in 16- to 23-Year Old Women - The FUTURE II Study (Females United to Unilaterally Reduce Endo/Ectocervical Disease)
• In February 2025, Shanghai Bovax Biotechnology Co., Ltd announced results of a Randomised, Double-blind, Placebo and Positive Controlled, Phase 2 Clinical Trial to Evaluate the Safety and Immunogenicity of 15-valent Human Papillomavirus Recombinant Vaccine (Hansenulapolymorpha) in Healthy Chinese People Aged 9-45 Years
• In March 2024, Merck announced plans to develop an innovative investigational multivalent HPV vaccine aimed at expanding protection across various HPV strains. Clinical trials will be conducted in both males and females to assess the safety and efficacy of a single-dose regimen of GARDASIL 9 compared to the existing three-dose regimen, promising broader protection
• In March 2024, Verrica Pharmaceuticals Inc. revealed that its lead medication, YCANTH, has earned New Chemical Entity (NCE) status from the U.S. FDA. This designation, along with its listing in the FDA's Orange Book, ensures at least five years of regulatory exclusivity, significantly enhancing the company's market position and competitive edge
• In January 2024, Verrica Pharmaceuticals Inc. announced the receival of minutes from the Company's latest Type C meeting with the United States FDA, which occurred on November 6, 2023, for reviewing the Phase 3 clinical development strategy for YCANTH for common warts treatment.
• Novan Inc: Novan Inc is actively working on SB 207, a topical treatment for genital warts, with clinical trials ongoing as of April 2024.
• pHion Therapeutics: pHion Therapeutics is developing PTX_V1, a potential drug candidate for genital warts, with updates reported as of April 2024.
• Cassiopeia: Cassiopeia is involved in the development of Anti-DNA Virus Program, with clinical trials ongoing as of April 2024.
• Innovax: Innovax is working on Ranpirnase, a potential treatment for genital warts, with clinical trials ongoing as of April 2024.
Genital Warts Overview
Genital warts are a common sexually transmitted infection (STI) caused by certain strains of the human papillomavirus (HPV). Genital warts appear as small, flesh-colored or grey growths in the genital area and can affect both men and women. Genital warts are spread through skin-to-skin contact during getting physical with an infected person. Genital warts may not always be visible immediately and can take weeks or even months to appear after infection.
Genital warts symptoms include itching, discomfort, and the presence of soft bumps in the genital region. Genital warts can occur in clusters and may sometimes bleed during intercourse. Genital warts are typically diagnosed through a physical exam by a healthcare provider. Genital warts can be treated with topical medications, cryotherapy (freezing), or minor surgical procedures, though the virus may remain dormant in the body.
Genital warts prevention includes HPV vaccination, practicing safe sex, and regular STI screenings. Genital warts are not life-threatening but can cause emotional distress and complications during pregnancy. Genital warts recurrence is possible even after treatment. Genital warts management requires consistent medical follow-up and safe sexual practices. Genital warts awareness and early treatment are crucial for controlling spread and improving quality of life.
Get a Free Sample PDF Report to know more about Genital Warts Pipeline Therapeutic Assessment- https://www.delveinsight.com/sample-request/genital-warts-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Genital Warts Route of Administration
Genital Warts pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Infusion
• Intradermal
• Intramuscular
• Intranasal
• Intravenius
• Oral
• Parenteral
• Subcutaneous
• Topical.
Genital Warts Molecule Type
Genital Warts Products have been categorized under various Molecule types, such as
• Gene therapies
• Small molecule
• Vaccines
• Polymers
• Peptides
• Monoclonal antibodies
Genital Warts Pipeline Therapeutics Assessment
• Genital Warts Assessment by Product Type
• Genital Warts By Stage and Product Type
• Genital Warts Assessment by Route of Administration
• Genital Warts By Stage and Route of Administration
• Genital Warts Assessment by Molecule Type
• Genital Warts by Stage and Molecule Type
DelveInsight's Genital Warts Report covers around 30+ products under different phases of clinical development like-
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration
Further Genital Warts product details are provided in the report. Download the Genital Warts pipeline report to learn more about the emerging Genital Warts therapies- https://www.delveinsight.com/report-store/genital-warts-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Genital Warts Pipeline Analysis:
The Genital Warts pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Genital Warts with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Genital Warts Treatment.
• Genital Warts key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Genital Warts Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Genital Warts market.
Download Sample PDF Report to know more about Genital Warts drugs and therapies- https://www.delveinsight.com/sample-request/genital-warts-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Scope of Genital Warts Pipeline Drug Insight
• Coverage: Global
• Key Genital Warts Companies: ViroXis Corporation, bioRASI, LLC, Verrica Pharmaceuticals Inc. (NASDAQ: VRCA), Orgenesis (NASDAQ: ORGS), Heber Biotec, Cassiopea (SWX: SKIN), Novan (NASDAQ: NOVN), Peritech Pharma, Novartis (SWX: NOVN), and others.
• Key Genital Warts Therapies: VP-102, SB206, CB-06-02, and others.
• Genital Warts Therapeutic Assessment: Genital Warts current marketed and Genital Warts emerging therapies
• Genital Warts Market Dynamics: Genital Warts market drivers and Genital Warts market barriers
Request for Sample PDF Report for Genital Warts Pipeline Assessment and clinical trials - https://www.delveinsight.com/sample-request/genital-warts-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Contents
1. Genital Warts Report Introduction
2. Genital Warts Executive Summary
3. Genital Warts Overview:
4. Genital Warts- Analytical Perspective In-depth Commercial Assessment
5. Genital Warts Pipeline Therapeutics
6. Genital Warts Late Stage Products (Phase II/III)
7. Genital Warts Mid Stage Products (Phase II)
8. Genital Warts Early Stage Products (Phase I)
9. Genital Warts Preclinical Stage Products
10. Genital Warts Therapeutics Assessment
11. Genital Warts Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Genital Warts Companies
14. Genital Warts Key Products
15. Genital Warts Unmet Needs
16 . Genital Warts Market Drivers and Barriers
17. Genital Warts Future Perspectives and Conclusion
18. Genital Warts Analyst Views
19. Appendix
20. About DelveInsight
Related Reports:
• Trigeminal Neuralgia Market Size: https://www.delveinsight.com/report-store/chronic-pain-market
• Ventricular Fibrillation Market: https://www.delveinsight.com/report-store/electrophysiology-devices-market
• Adamantinoma Market: https://www.delveinsight.com/blog/bone-cancer-treatment-market
• Healthcare Subscription Models: https://www.delveinsight.com/blog/subscription-model-in-healthcare
• Healthcare Competitive Benchmarking: https://www.delveinsight.com/consulting/competitive-benchmarking-services
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Benefits Of Robotics In Healthcare: https://www.delveinsight.com/blog/robotics-in-healthcare
• Wound Irrigation Systems Market: https://www.delveinsight.com/report-store/wound-irrigation-systems-market?utm_source=Medgadget&utm_medium=pressrelease&utm_campaign=kupr
• Pulse Oximeter Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Gaucher Disease Market: https://www.delveinsight.com/report-store/gauchers-disease-market
• Anti-cd274 Pd-l1 Antibody Pipeline: https://www.delveinsight.com/report-store/pd-1-and-pd-l1-inhibitors-competitive-landscape
• Apheresis Market: https://www.delveinsight.com/report-store/apheresis-market
• Atherectomy Devices Market: https://www.delveinsight.com/report-store/atherectomy-devices-market
• Hearing Implants Market: https://www.delveinsight.com/report-store/hearing-implants-market
• Menopause Market: https://www.delveinsight.com/report-store/menopause-market
• Ophthalmic Imaging Equipment Market: https://www.delveinsight.com/report-store/ophthalmic-imaging-equipment-market
• Aortic Aneurysm Stent Grafts Market: https://www.delveinsight.com/report-store/aortic-aneurysm-stent-grafts-market
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/report-store/blood-glucose-monitoring-systems-market
• Chronic Lymphocytic Leukemia Cll Market: https://www.delveinsight.com/report-store/chronic-lymphocytic-leukemia-cll-market
• Healthcare Due Diligence Services: https://www.delveinsight.com/consulting/due-diligence-services
• Pressure Ulcers Market: https://www.delveinsight.com/report-store/pressure-ulcers-market
• Pulse Oximeters Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Diabetic Foot Ulcers Dfus Market: https://www.delveinsight.com/report-store/diabetic-foot-ulcers-dfus-market
• Energy Based Aesthetic Devices Market: https://www.delveinsight.com/report-store/energy-based-aesthetic-devices-market
• Hepatitis B Virus Market: https://www.delveinsight.com/report-store/chronic-hepatitis-b-virus-market
• Minimal Residual Disease Market: https://www.delveinsight.com/report-store/minimal-residual-disease-market
• Vertigo Market: https://www.delveinsight.com/report-store/vertigo-market
• Chronic Hepatitis B Virus Market: https://www.delveinsight.com/report-store/chronic-hepatitis-b-virus-market
• Neuroprosthetics Market: https://www.delveinsight.com/blog/neuroprosthetics-market-analysis
• Non Alcoholic Fatty Liver Disease Nafld Market: https://www.delveinsight.com/report-store/non-alcoholic-fatty-liver-disease-nafld-market
• Palmar Hyperhidrosis Market: https://www.delveinsight.com/report-store/palmar-hyperhidrosis-market
• Acute Pain Market: https://www.delveinsight.com/report-store/acute-pain-market
• Automated External Defibrillators Market: https://www.delveinsight.com/report-store/external-defibrillators-market
• Dysthymia Market: https://www.delveinsight.com/report-store/persistent-depressive-disorder-market?utm_source=globenewswire&utm_medium=pressrelease&utm_campaign=spr
• Interbody Cages Market: https://www.delveinsight.com/report-store/interbody-cages-market
• Osteoarthritis Market: https://www.delveinsight.com/report-store/knee-osteoarthritis-market
• Palmar Hyperhidrosis Market Size: https://www.delveinsight.com/report-store/palmar-hyperhidrosis-market
• Wet-age Related Macular Degeneration Market: https://www.delveinsight.com/report-store/wet-age-related-macular-degeneration-wet-amd-market
• X Linked Hypophosphatemia Market: https://www.delveinsight.com/report-store/x-linked-hypophosphatemia-market
• Absssi Market Size: https://www.delveinsight.com/report-store/acute-bacterial-skin-and-skin-structure-infections-market
• Age-related Macular Degeneration Market: https://www.delveinsight.com/report-store/age-related-macular-degeneration-amd-market
• Androgenetic Alopecia Market: https://www.delveinsight.com/report-store/androgenetic-alopecia-market
• Arthroscopy Devices Market: https://www.delveinsight.com/report-store/arthroscopy-devices-market
• Artificial Kidney Market: https://www.delveinsight.com/report-store/artificial-kidney-market
• Carpal Tunnel Syndrome Market: https://www.delveinsight.com/report-store/carpal-tunnel-syndrome-market
• Central Pain Syndrome Market: https://www.delveinsight.com/report-store/central-pain-syndrome-market
• Cough Assisted Device Market: https://www.delveinsight.com/report-store/cough-assist-devices-market
• Duchenne Muscular Dystrophy Market: https://www.delveinsight.com/blog/duchenne-muscular-dystrophy-market
• Hearing Aid Devices Market: https://www.delveinsight.com/report-store/audiology-devices-market
• Neurovascular Devices Market: https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market
• Prefilled Syringes Market: https://www.delveinsight.com/report-store/prefilled-syringes-market
• Xerostomia Market: https://www.delveinsight.com/report-store/xerostomia-market
Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Genital Warts Clinical Trials Assessment 2025: PDMA, EMA, FDA Approvals, Medication, IND, NDA Approval, Therapies, Mechanism of Action, NICE Approvals, Route of Administration and Companies by DelveInsight here
News-ID: 3997880 • Views: …
More Releases from DelveInsight Business Research
KRAS Inhibitors Market Expected to Experience Major Growth by 2034, According to …
DelveInsight's "KRAS Inhibitors Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the KRAS Inhibitors, historical and forecasted epidemiology as well as the KRAS Inhibitors market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the KRAS Inhibitors market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; KRAS Inhibitors Market Forecast
https://www.delveinsight.com/sample-request/kras-inhibitors-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Neuroendocrine Tumor Market Set to Grow Substantially Through 2034, DelveInsight …
The Neuroendocrine Tumor market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Neuroendocrine Tumor pipeline products will significantly revolutionize the Neuroendocrine Tumor market dynamics.
DelveInsight's "Neuroendocrine Tumor Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Neuroendocrine Tumor, historical and forecasted epidemiology as well as the Neuroendocrine Tumor market trends in the United…
Pancreatic Cancer Market to Show Remarkable Growth Trends from 2024 to 2034, Del …
The Pancreatic Cancer market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage pipeline products will significantly revolutionize the Pancreatic Cancer market dynamics.
DelveInsight's "Pancreatic Cancer Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of Pancreatic Cancer, historical and forecasted epidemiology as well as the Pancreatic Cancer market trends in the United States, EU5 (Germany,…
Antibody Drug Conjugates Market Predicted to See Upsurge Through 2034, Highlight …
DelveInsight's "Antibody Drug Conjugates Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Antibody Drug Conjugates, historical and forecasted epidemiology as well as the Antibody Drug Conjugates market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Antibody Drug Conjugates market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Antibody Drug Conjugates Market…
More Releases for Genital
Rising Sexual Health Awareness To Drive Genital Herpes Market Growth: A Key Driv …
The Genital Herpes Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Genital Herpes Market Size and Its Estimated Growth Rate?
The genital herpes market has experienced strong growth in recent years. It will grow from $2.19 billion in 2024 to $2.34 billion…
Rising Sexually Transmitted Infection (STI) Rates Propel Growth In Genital Warts …
The Genital Warts Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Genital Warts Market Size and Projected Growth Rate?
The genital warts market has grown strongly in recent years. It is set to increase from $1.97 billion in 2024 to $2.08 billion in…
Genital Warts Market - Revolutionizing Intimate Care: Transforming the Genital W …
Newark, New Castle, USA: The "Genital Warts Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Genital Warts Market: https://www.growthplusreports.com/report/genital-warts-market/8677
This latest report researches the industry structure, sales, revenue,…
Genital Warts Market to Witness Growth by 2032, Estimates DelveInsight
DelveInsight's "Genital Warts Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Genital Warts, historical and forecasted epidemiology as well as the Genital Warts market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Genital Warts market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Genital Warts market size…
Genital Herpes - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Genital Herpes - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Genital Herpes - Pipeline Review, H1 2017, provides an overview of the Genital Herpes (Infectious Disease) pipeline landscape.
Genital herpes is a common sexually transmitted infection that affects both men and women. Genital herpes is caused…
Genital Herpes - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Thyroid Cancer - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Thyroid Cancer – Pipeline Review, H1 2017, provides an overview of the Thyroid Cancer (Oncology) pipeline landscape.
Thyroid cancer is a cancer that starts in the thyroid gland. Symptoms include lump that can be felt through…
